- Provectus Pharmaceuticals Announces Financial Results for Year End ... - FOXBusiness
- Polydex Announces Ushercell Prevents Systemic HIV Infection in ... - FOXBusiness
- Generex Biotechnology to Make Presentations At International ... - FOXBusiness
- Generex Biotechnology Raises $20650000 Through Private Placement - FOXBusiness
- Abraxis BioScience Reports 83% Revenue Growth to a Record $334 ... - FOXBusiness
Crucell Announces Start of Phase II Clinical Study Rabies ... - FOXBusiness
Crucell Announces Start of Phase II Clinical Study Rabies ...FOXBusiness - 1 hour agoPhase I clinical trials conducted in the United States and India demonstrated safety and the ability to protect. The antibody combination is well tolerated, ...
